Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 5,062 | 2,874 | 0 | 0 | 0 |
| Gross Profit | 5,062 | 2,874 | N/A | N/A | N/A |
| Operating Expenses | 25,530 | 20,687 | 17,124 | 14,571 | 12,956 |
| Operating Income | -20,468 | -17,813 | -17,124 | -14,571 | -12,956 |
| Other Income | 1,002 | 467 | 311 | 368 | 367 |
| Pre-tax Income | -19,466 | -17,346 | -16,813 | -14,203 | -12,589 |
| Income Tax | -66 | -152 | -46 | -26 | -145 |
| Net Income Continuous | -19,400 | -17,194 | -16,767 | -14,177 | -12,444 |
| Net Income | $-19,400 | $-17,194 | $-16,767 | $-14,177 | $-12,444 |
| EPS Basic Total Ops | -18.37 | -18.73 | -18.37 | -13.69 | -13.69 |
| EPS Basic Continuous Ops | -18.37 | -18.59 | -18.48 | -13.66 | -13.75 |
| EPS Diluted Total Ops | -18.37 | -18.73 | -18.37 | -13.69 | -13.69 |
| EPS Diluted Continuous Ops | -18.37 | -18.59 | -18.48 | -13.66 | -13.75 |
| EBITDA(a) | $-21,007 | $-18,041 | $-17,216 | $-14,672 | $-13,024 |